# Iodine

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/iodine

- Industry: Internet
- Headquarters: San Francisco, US
- Website: www.iodine.com
- Latest round: Seed (Feb 28, 2014)
- Investors on record: 2

## About

Iodine, Inc. is a healthcare technology company that utilizes advanced data analytics and artificial intelligence to enhance the accuracy of medication prescriptions and improve patient outcomes.Founded in 2013 in San Francisco, US, Iodine, Inc. specializes in using data-driven solutions to optimize medication management. The company was acquired by GoodRx, Inc. in November 2016, marking a strategic pivot to integrate its technology within a larger healthcare marketplace. Founders Bruno Danis and Nay Lwin have backgrounds in technology and healthcare, having contributed to various innovations in the sector.Iodine, Inc. offers a suite of healthcare technology products designed to improve prescription accuracy and streamline medication management for healthcare providers. Their platform leverages data analytics to provide actionable insights for clinicians, helping them make informed prescribing decisions. The services are targeted at hospitals, clinics, and healthcare professionals, enabling them to enhance patient care through improved medication safety and adherence.Iodine, Inc.'s revenue model is primarily based on partnerships with healthcare institutions and subscription services for access to their technology platform. The company generates income through agreements with healthcare facilities, allowing them to utilize Iodine’s analytics for better medication management and patient outcomes. Specific revenue figures have not been disclosed.Looking ahead, Iodine, Inc. plans to expand its product offerings by developing new features aimed at further enhancing prescription accuracy, with anticipated launches in the upcoming year. The company also seeks to penetrate new markets, particularly targeting urban hospitals in the US, with an expansion timeline set for late 2023. The acquisition by GoodRx in November 2016 has provided the necessary resources to support these growth initiatives, enabling Iodine to leverage GoodRx's extensive network to broaden its reach within the healthcare community.

## Funding rounds

- Seed, Feb 28, 2014 — MESA+, SparkLabs Global Ventures

## Investors

- MESA+ (https://capitalatlas.ai/funds/mesa) — Seed
- SparkLabs Global Ventures (https://capitalatlas.ai/funds/sparklabs-global-ventures) — Seed